Cargando…
Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: A case report
RATIONALE: There are roughly 5 to 10 million persons infected with human T-lymphotropic virus type 1 (HTLV-1) worldwide, and the safety of treating this population with biologics remains poorly understood. PATIENT CONCERNS AND DIAGNOSIS: An HTLV-1-infected 66-year-old female with HTLV-1 uveitis (HU)...
Autores principales: | Terada, Yukiko, Kamoi, Koju, Ohno-Matsui, Kyoko, Miyata, Kazunori, Yamano, Chinami, Coler-Reilly, Ariella, Yamano, Yoshihisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312999/ https://www.ncbi.nlm.nih.gov/pubmed/28178142 http://dx.doi.org/10.1097/MD.0000000000006021 |
Ejemplares similares
-
Updates on HTLV-1 Uveitis
por: Kamoi, Koju, et al.
Publicado: (2022) -
Mechanism of Secondary Glaucoma Development in HTLV-1 Uveitis
por: Zong, Yuan, et al.
Publicado: (2022) -
Safety of intraocular anti-VEGF antibody treatment under in vitro HTLV-1 infection
por: Zong, Yuan, et al.
Publicado: (2023) -
HTLV-1 in Ophthalmology
por: Kamoi, Koju
Publicado: (2020) -
In vitro Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study
por: Kurozumi-Karube, Hisako, et al.
Publicado: (2020)